Optimization of Diclofenac Sodium-Loaded Nanostructured Lipid Carriers (NLCs) Using the Box-Behnken Design

Article Preview

Abstract:

This study aimed to prepare diclofenac sodium (DCF)–loaded nanostructured lipid carriers (NLCs) (DCF-loaded NLCs) for optimizing the NLCs by using the Box-Behnken design. A hot emulsification method using an ultrasonic probe was employed to prepare DCF-loaded NLCs. The active ingredient, solid lipid, oil, and emulsifier were DCF, glyceryl monostearate (GMS) (X1), oleic acid (X2), and polysorbate 80 (X3), respectively. The DCF-loaded NLCs had particle sizes of 69.29–187.3 nm. The polydispersity index (PDI) was in the range of 0.216–0.516, indicating a relatively narrow size distribution. The zeta potential of all formulations revealed the negative charge and ranged between -26.0 and -42.13 mV. The percentage encapsulation efficiency (%EE) was 92.71%–104.21%. The responses of all model formulations were created and the optimized formulation was selected by Design-Expert® software. The optimal formulation was composed of 2 g GMS, 0.926 g oleic acid, and 2.724 g polysorbate 80. The particle size and PDI experimental values with the optimal formulation did not differ from those predicted and were within the 95% CI. Therefore, the Box-Behnken design could be efficient in formulating and optimizing DCF-loaded NLCs.

You might also be interested in these eBooks

Info:

Periodical:

Pages:

137-143

Citation:

Online since:

October 2021

Export:

Price:

Permissions CCC:

Permissions PLS:

Сopyright:

© 2021 Trans Tech Publications Ltd. All Rights Reserved

Share:

Citation:

* - Corresponding Author

[1] S. Kittiwisut, P. Kraisit, Physicochemical characterization of propranolol-loaded chitosan nanoparticles for a buccal drug delivery, Int. J. Appl. Pharm. (2020) 243–247.

DOI: 10.22159/ijap.2020v12i4.38009

Google Scholar

[2] P. Kraisit, S. Limmatvapirat, J. Nunthanid, P. Sriamornsak, M. Luangtana-anan, Nanoparticle formation by using shellac and chitosan for a protein delivery system., Pharm. Dev. Technol. 18 (2013) 686–693.

DOI: 10.3109/10837450.2012.685657

Google Scholar

[3] P. Kraisit, S. Limmatvapirat, M. Luangtana-Anan, P. Sriamornsak, Buccal administration of mucoadhesive blend films saturated with propranolol loaded nanoparticles, Asian J. Pharm. Sci. 13 (2018) 34–43.

DOI: 10.1016/j.ajps.2017.07.006

Google Scholar

[4] P. Kraisit, N. Sarisuta, Development of triamcinolone acetonide-loaded nanostructured lipid carriers (NLCs) for buccal drug delivery using the box-behnken design, Molecules. 23 (2018).

DOI: 10.3390/molecules23040982

Google Scholar

[5] C. Tetyczka, M. Griesbacher, M. Absenger-Novak, E. Fröhlich, E. Roblegg, Development of nanostructured lipid carriers for intraoral delivery of Domperidone, Int. J. Pharm. 526 (2017) 188–198.

DOI: 10.1016/j.ijpharm.2017.04.076

Google Scholar

[6] J. Pardeike, A. Hommoss, R.H. Müller, Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products, Int. J. Pharm. 366 (2009) 170–184.

DOI: 10.1016/j.ijpharm.2008.10.003

Google Scholar

[7] V. Teeranachaideekul, P. Boonme, E.B. Souto, R.H. Müller, V.B. Junyaprasert, Influence of oil content on physicochemical properties and skin distribution of Nile red-loaded NLC, J. Control. Release. 128 (2008) 134–141.

DOI: 10.1016/j.jconrel.2008.02.011

Google Scholar

[8] Y. Chu, D. Li, Y.-F. Luo, X.-J. He, M.-Y. Jiang, Preparation and In Vitro Evaluation of Glycyrrhetinic Acid-Modified Curcumin-Loaded Nanostructured Lipid Carriers, Mol. 19 (2014).

DOI: 10.3390/molecules19022445

Google Scholar

[9] A. Kovacevic, S. Savic, G. Vuleta, R.H. Müller, C.M. Keck, Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): Effects on size, physical stability and particle matrix structure, Int. J. Pharm. 406 (2011) 163–172.

DOI: 10.1016/j.ijpharm.2010.12.036

Google Scholar

[10] D. Zakowiecki, M. Szczepanska, T. Hess, K. Cal, B. Mikolaszek, J. Paszkowska, M. Wiater, D. Hoc, G. Garbacz, Preparation of delayed-release multiparticulate formulations of diclofenac sodium and evaluation of their dissolution characteristics using biorelevant dissolution methods, J. Drug Deliv. Sci. Technol. 60 (2020) 101986.

DOI: 10.1016/j.jddst.2020.101986

Google Scholar

[11] P. Kraisit, S. Limmatvapirat, J. Nunthanid, P. Sriamornsak, M. Luangtana-Anan, Preparation and characterization of hydroxypropyl methylcellulose/polycarbophil mucoadhesive blend films using a mixture design approach, Chem. Pharm. Bull. 65 (2017) 284–294.

DOI: 10.1248/cpb.c16-00849

Google Scholar

[12] P. Kraisit, Impact of hydroxypropyl methylcellulose (HPMC) type and concentration on the swelling and release properties of propranolol hydrochloride matrix tablets usning a simplex centroid design, Int. J. Appl. Pharm. 11 (2019) 143–151.

DOI: 10.22159/ijap.2019v11i2.31127

Google Scholar

[13] S. Sood, K. Jain, K. Gowthamarajan, Optimization of curcumin nanoemulsion for intranasal delivery using design of experiment and its toxicity assessment, Colloids Surfaces B Biointerfaces. 113 (2014) 330–337.

DOI: 10.1016/j.colsurfb.2013.09.030

Google Scholar

[14] Z. Rahman, A.S. Zidan, M.A. Khan, Non-destructive methods of characterization of risperidone solid lipid nanoparticles, Eur. J. Pharm. Biopharm. 76 (2010) 127–137.

DOI: 10.1016/j.ejpb.2010.05.003

Google Scholar

[15] H. Chaudhary, K. Kohli, S. Amin, P. Rathee, V. Kumar, Optimization and Formulation Design of Gels of Diclofenac and Curcumin for Transdermal Drug Delivery by Box-Behnken Statistical Design, J. Pharm. Sci. 100 (2011) 580–593.

DOI: 10.1002/jps.22292

Google Scholar

[16] S. Duangjit, P. Kraisit, Optimization of orodispersible and conventional tablets using simplex lattice design: Relationship among excipients and banana extract, Carbohydr. Polym. 193 (2018).

DOI: 10.1016/j.carbpol.2018.03.087

Google Scholar

[17] S. Duangjit, P. Kraisit, M. Luangtana-Anan, An investigation of propranolol-loaded chitosan nanoparticles for transmucosal delivery: Physical characterization, Thai J. Pharm. Sci. 40 (2016).

Google Scholar

[18] P. Kraisit, N. Hirun, J. Mahadlek, S. Limmatvapirat, Fluconazole-loaded solid lipid nanoparticles (SLNs) as a potential carrier for buccal drug delivery of oral candidiasis treatment using the Box-Behnken design, J. Drug Deliv. Sci. Technol. 63 (2021) 102437.

DOI: 10.1016/j.jddst.2021.102437

Google Scholar

[19] S.M.M. Moghddam, A. Ahad, M. Aqil, S.S. Imam, Y. Sultana, Optimization of nanostructured lipid carriers for topical delivery of nimesulide using Box–Behnken design approach, Artif. Cells, Nanomedicine, Biotechnol. 45 (2017) 617–624.

DOI: 10.3109/21691401.2016.1167699

Google Scholar

[20] S. El-Housiny, M.A. Shams Eldeen, Y.A. El-Attar, H.A. Salem, D. Attia, E.R. Bendas, M.A. El-Nabarawi, Fluconazole-loaded solid lipid nanoparticles topical gel for treatment of pityriasis versicolor: formulation and clinical study, Drug Deliv. 25 (2018) 78–90.

DOI: 10.1080/10717544.2017.1413444

Google Scholar